World Health Organization (WHO) said that a number of treatments are under clinical trials for the treatment of COVID-19
Geneva: The World Health Organization (WHO) said that a number of treatments are under clinical trials for the treatment of COVID-19, but none of those were yet approved.
“There are hundreds of clinical trials that are underway, and the reason we need to wait for the results of these studies is because they are evaluating how these medicines, how these drugs work, in terms of either preventing infection, preventing someone from progressing to severe disease, preventing death and how safe they are, do they have any side effects,” Maria Van Kerkhove, technical lead for the WHO’s Health Emergencies Program, said on Friday in a press conference in Geneva, Xinhua news agency reported.
“Right now, WHO has launched the ‘Solidarity Trial’ which is a clinical trial focusing on some drugs, some therapeutics, to look at whether or not these are safe and effective for COVID-19. There are more than 2,500 patients enrolled in this multi-site clinical trial,” she said.
“And it will take some time before we have full answers to which treatments work, but right now we don’t have any approved treatments for COVID-19.” she added.
Michael Ryan, executive director of the WHO Health Emergencies Program, stressed the importance of proper process to ensure safety.
“And there’s a very very well tested process of doing this, so it’s really important that we encourage innovation, we encourage people to be looking for solutions, but then as those solutions potentially become available, we need to put them through the proper process in the interest of safety, in the interest of efficacy and in order to make sure that we first do no harm,” he said.
The British School New Delhi Celebrates 20 Years of the IB Diploma Programme
IIT Madras, SLGS team up to develop early diabetes detection tools
PM Modi dials new Nepal counterpart, pledges ‘steadfast support’ as nation reels from deadly unrest
Smuggled Turkish pistols used in Disha Patani home attack traced to Pakistan drone routes
Delhi schools to introduce student governance, entrepreneurship and mindfulness programs
PM Modi dials new Nepal counterpart, pledges ‘steadfast support’ as nation reels from deadly unrest
India says it will study implications of Pakistan-Saudi defense pact for national security
US names 23 countries including India, China, Pakistan, and Afghanistan as major drug transit or illicit drug-producing nations
New India strikes fear, not just terror: PM Modi highlights Jaish losses in Operation Sindoor
Rewriting history at Sarnath: ASI moves to credit Benares ruler over British archaeologists
The British School New Delhi Celebrates 20 Years of the IB Diploma Programme
IIT Madras, SLGS team up to develop early diabetes detection tools
PM Modi dials new Nepal counterpart, pledges ‘steadfast support’ as nation reels from deadly unrest
Smuggled Turkish pistols used in Disha Patani home attack traced to Pakistan drone routes
Delhi schools to introduce student governance, entrepreneurship and mindfulness programs
PM Modi dials new Nepal counterpart, pledges ‘steadfast support’ as nation reels from deadly unrest
India says it will study implications of Pakistan-Saudi defense pact for national security
US names 23 countries including India, China, Pakistan, and Afghanistan as major drug transit or illicit drug-producing nations
New India strikes fear, not just terror: PM Modi highlights Jaish losses in Operation Sindoor
Rewriting history at Sarnath: ASI moves to credit Benares ruler over British archaeologists
Copyright© educationpost.in 2024 All Rights Reserved.
Designed and Developed by @Pyndertech